Novo Nordisk's pricing approaches during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of price gouging, stating the stark distinction involving U.S. costs and people in Europe and copyright.In Oct 2024, Novo Nordisk released a analyze on scientific journal Mother nature about a novel glucose